Britney Dann, PA
Medical · Bee Caves, TXNPI 1962753947
Payments from drug & device makers
Across 810 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$2K
- Pfizer$1K
- Bristol Myers Squibb$831
- Sanofi$705
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 194 | $3,914 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 146 | $1,777 |
| Johnson & Johnson(2 entities) | 99 | $1,567 |
| Pfizer | 63 | $1,019 |
| Bristol Myers Squibb | 47 | $831 |
| Sanofi | 29 | $705 |
| Aimmune Therapeutics, Inc. | 36 | $513 |
| Celltrion USA Inc. | 30 | $459 |
| Redhill Biopharma Inc. | 34 | $350 |
| Ardelyx, Inc. | 20 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $270 |
| QOL Medical, LLC | 12 | $246 |
| Nestle Healthcare Nutrition Inc. | 12 | $227 |
| Lilly USA, LLC | 10 | $213 |
| Braintree Laboratories, Inc. | 10 | $209 |
| Ferring Pharmaceuticals Inc. | 10 | $177 |
| Ipsen Biopharmaceuticals, Inc | 8 | $172 |
| Phathom Pharmaceuticals, Inc. | 5 | $102 |
| Merck | 6 | $101 |
| Intercept Pharmaceuticals, Inc. | 5 | $75 |
| Janssen Scientific Affairs, LLC | 1 | $69 |
| Madrigal Pharmaceuticals | 3 | $66 |
| Ironwood Pharmaceuticals, Inc | 3 | $57 |
| UCB, Inc. | 2 | $39 |
| Organon | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $22 |
| Vivus LLC | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Gilead | 1 | $18 |
| Novo Nordisk | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$13,787 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Bee Caves
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.